does pfizer have a glp-1 drug glp 1 Danuglipron: An Oral GLP-1R Agonist Competing with Peptide Pfizer GLP-1 weight loss drug

But from a policy and budget standpoint, the math simply doesnt add up yet

Despite the substantial benefits of bariatric metabolic surgery in reducing body mass index (BMI) and improving comorbid conditions such as diabetes mellitus (DM), hypertension (HTN), and hyperlipidemia (HLP), WR, IWL, and other complications can hinder long-term success [4,5,6,7]

For instance, according to the International Diabetes Federation, 537 million individuals were affected by diabetes worldwide in 2021, with more than 75% of adult diabetes cases occurring in low and middle-income countries

GLP-1 therapy has also shown benefit in improving atherothrombosis markers (e.g., inflammation, endothelial dysfunction, clotting in this population)

Liver-targeting medications (such as resmetirom, fibroblast growth factor 21 analogs and lanifibranor), aiming at liver inflammation and collagen deposition, are expected to become crucial in individuals with more advanced liver disease [138]

Beta-cell-targeted overexpression of phosphodiesterase 3B in mice causes impaired insulin secretion, glucose intolerance, and deranged islet morphology